Lawsuit Alleges Takeda Pharmaceutical Co., Maker of Diabetes Drug Actos, Didn’t Warn of the Drug’s Risks Soon Enough; Parker Waichman LLP Responds
Published on Friday, 06 September 2013 13:00 Written by TradersHuddle Staff
Plaintiff’s counsel alleges that Takeda Pharmaceutical Co. knew about the dangers of its diabetes drug Actos “by 2005 at the latest,” but failed to issue a warning until six years afterward, Bloomberg reports. Parker Waichman LLC, which offers legal consultations to victims of injuries allegedly caused by Actos, including bladder cancer, responds.
New York, NY (PRWEB) September 06, 2013
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, notes that, according to a Sept. 4 Bloomberg report, during a trial over the diabetes drug Actos, a lawyer for the Plaintiff alleged Takeda Pharmaceutical Co. had failed to warn consumers about certain cancer risks related to the drug (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland).
Takeda officials knew by 2005 that studies had shown links between Actos and cancer and didn’t issue a warning until six years later, the lawyer alleged in opening arguments, according to the Bloomberg report.
The U.S. Food and Drug Administration (FDA), which approved Actos, has been warning of the risks of the drug since 2011. On June 15, 2011, the agency said that taking Actos for more than a year could significantly increase the risk of bladder cancer. The safety label on Actos was updated to address this risk.
“The FDA was among the first to determine the drug Actos can cause an elevated risk in bladder cancer among those who take it for around a year,” said Parker Waichman LLP. “At least now we seem to be on the same page about the potential dangers associated with this drug.”
Aside from the FDA, research studies from other groups provide additional support for the notion of a link between Actos and bladder cancer. The British Medical Journal published a study on May 31, 2012, that revealed Actos users were twice as likely to develop bladder cancer after two years. Then, on July 3, 2012, the Canadian Medical Association Journal reported that patients taking the medication were 22 percent more likely to get bladder cancer.
Parker Waichman LLP continues to offer free legal consultations to victims of injuries allegedly caused by Actos, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636
For the original version on PRWeb visit: http://www.prweb.com/releases/Actos_trial_Bloomberg/MM/prweb11098139.htm
- PV Enterprises International, Inc. (PVE) enters into an agreement with Invisosoft, Inc. ( A Global Visual Communications Company ) to develop a Maritime Visual Communication Platform
- PV Enterprises International announcement Time charter awarded.
- PV Enterprises International announces Time Charter awarded
- PV Enterprises International, Inc. Messages to shareholders regarding FINRA
- PV Enterprises International, Inc. (OTC Pink: VDSC) Announces the Spinoff of its subsidiary IMAG Group, Inc. formerly known as Red Tide Defense Group and the Filing with FINRA
- News Message from CEO of PV Enterprises International to its Shareholders
- Message from CEO to Shareholders
Related Partner Headlines
Recent Trading Ideas
Latest Partner Headlines